Fluticasone Propionate
Product Images NDC 53002-1401

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 53002-1401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)
FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)
FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)
FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)
FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

Figure A (Fluticasonepropionatehfa Spl Graphic 05)
Metal Canister, Dark Orange Plastic Actuator, Dark Orange Mouthpiece, Peach Cap.*
FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

Figure B (Fluticasonepropionatehfa Spl Graphic 06)
FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

Figure C (Fluticasonepropionatehfa Spl Graphic 07)
FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

Figure D (Fluticasonepropionatehfa Spl Graphic 08)
FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

Figure E (Fluticasonepropionatehfa Spl Graphic 09)
FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

Figure F (Fluticasonepropionatehfa Spl Graphic 10)
FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

Figure G (Fluticasonepropionatehfa Spl Graphic 11)
FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

Figure H (Fluticasonepropionatehfa Spl Graphic 12)
FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

Figure I (Fluticasonepropionatehfa Spl Graphic 13)
FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

Figure J (Fluticasonepropionatehfa Spl Graphic 14)
FDA Label Image

Label Image (Lbl530021401)

Label Image (Lbl530021401)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.